For the quarter ended June 2026, Ardelyx (ARDX) reported revenue of $120.88 million, up 23.8% over the same period last year. EPS came in at -$0.07, compared to -$0.08 in the year-ago quarter.
The reported revenue compares to the Zacks Consensus Estimate of $123.69 million, representing a surprise of -2.27%. The company delivered an EPS surprise of -40%, with the consensus EPS estimate being -$0.05.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Ardelyx performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenues- Product sales, net: $118.13 million versus $122.71 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +31.1% change. Revenues- Product sales, net- IBSRELA: $86.24 million compared to the $97.86 million average estimate based on four analysts. The reported number represents a change of +32.6% year over year. Revenues- Product sales, net- XPHOZAH: $31.89 million compared to the $27.96 million average estimate based on four analysts. The reported number represents a change of +27.4% year over year. Revenues- Licensing: $0.1 million versus the two-analyst average estimate of $0.06 million. The reported number represents a year-over-year change of +380%.View all Key Company Metrics for Ardelyx here>>>
Shares of Ardelyx have returned -9.6% over the past month versus the Zacks S&P 500 composite's +3.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Ardelyx, Inc. (ARDX): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).